BRPI0411985A - tratamento da disfunção sexual - Google Patents

tratamento da disfunção sexual

Info

Publication number
BRPI0411985A
BRPI0411985A BRPI0411985-1A BRPI0411985A BRPI0411985A BR PI0411985 A BRPI0411985 A BR PI0411985A BR PI0411985 A BRPI0411985 A BR PI0411985A BR PI0411985 A BRPI0411985 A BR PI0411985A
Authority
BR
Brazil
Prior art keywords
treatment
sexual dysfunction
sexual
dysfunction
disorder
Prior art date
Application number
BRPI0411985-1A
Other languages
English (en)
Inventor
Alasdair Mark Naylor
Pieter Hadewijn Van Der Graaf
Christopher Peter Wayman
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0316673A external-priority patent/GB0316673D0/en
Priority claimed from GB0318095A external-priority patent/GB0318095D0/en
Priority claimed from GB0321308A external-priority patent/GB0321308D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of BRPI0411985A publication Critical patent/BRPI0411985A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"TRATAMENTO DA DISFUNçãO SEXUAL". A presente invenção refere-se com a utilização de inibidores de guanosina-3<39>,5<39>-monofosfato cíclico-fosfodiesterase de tipo cinco (PDE5), associados a agonistas de 5HT1a para o tratamento de disfunção sexual, em particular do distúrbio da excitação sexual feminina (FSAD) com distúrbio do desejo sexual hipoativo (HSDD) concomitante.
BRPI0411985-1A 2003-07-16 2004-07-12 tratamento da disfunção sexual BRPI0411985A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0316673A GB0316673D0 (en) 2003-07-16 2003-07-16 Treatment of female sexual dysfunction
GB0318095A GB0318095D0 (en) 2003-08-01 2003-08-01 Treatment of sexual dysfunction
GB0321308A GB0321308D0 (en) 2003-09-11 2003-09-11 Treatment of sexual dysfunction
PCT/IB2004/002286 WO2005007166A1 (en) 2003-07-16 2004-07-12 Treatment of sexual dysfunction

Publications (1)

Publication Number Publication Date
BRPI0411985A true BRPI0411985A (pt) 2006-08-29

Family

ID=34084177

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0411985-1A BRPI0411985A (pt) 2003-07-16 2004-07-12 tratamento da disfunção sexual

Country Status (7)

Country Link
EP (1) EP1653966A1 (pt)
JP (1) JP2007516949A (pt)
BR (1) BRPI0411985A (pt)
CA (1) CA2532252A1 (pt)
MX (1) MXPA06000623A (pt)
TW (1) TW200505410A (pt)
WO (1) WO2005007166A1 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA78974C2 (en) 2001-10-20 2007-05-10 Boehringer Ingelheim Pharma Use of flibanserin for treating disorders of sexual desire
US10675280B2 (en) 2001-10-20 2020-06-09 Sprout Pharmaceuticals, Inc. Treating sexual desire disorders with flibanserin
AR048128A1 (es) 2003-12-01 2006-04-05 Akzo Nobel Nv Un tratamiento de la difuncion sexual
CA2563743A1 (en) * 2004-04-22 2005-11-03 Boehringer Ingelheim International Gmbh New pharmaceutical compositions for the treatment of sexual disorders ii
US20050239798A1 (en) * 2004-04-22 2005-10-27 Boehringer Ingelheim Pharmaceuticals, Inc. Method for the treatment of premenstrual and other female sexual disorders
PL1750766T3 (pl) 2004-05-11 2013-12-31 Eb Ip Lybrido B V Preparaty farmaceutyczne i ich zastosowania do leczenia zaburzeń seksualnych u kobiet
JP2009503020A (ja) 2005-08-03 2009-01-29 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 肥満症の治療におけるフリバンセリンの使用
WO2007048803A1 (en) * 2005-10-29 2007-05-03 Boehringer Ingelheim International Gmbh Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders
US20070123540A1 (en) * 2005-10-29 2007-05-31 Angelo Ceci Sexual desire enhancing medicaments comprising benzimidazolone derivatives
EP1790343A1 (en) 2005-11-11 2007-05-30 Emotional Brain B.V. Pharmaceuticals formulations and uses thereof in the treatment of female sexual dysfunction
NZ573382A (en) * 2006-05-09 2012-02-24 Boehringer Ingelheim Int Use of flibanserin for the treatment of post-menopausal sexual desire disorders
EP2037927B1 (en) 2006-06-30 2010-01-27 Boehringer Ingelheim International GmbH Flibanserin for the treatment of urinary incontinence and related diseases
BRPI0716439B8 (pt) 2006-08-14 2021-05-25 Boehringer Ingelheim Int sistemas de liberação farmacêutico compreendendo flibanserina, processo para preparação e uso dos mesmos
CL2007002214A1 (es) 2006-08-14 2008-03-07 Boehringer Ingelheim Int Composicion farmaceutica en la forma de comprimido, donde al menos la longitud del comprimido en el estado anterior de la aplicacion es al menos 7/12 del diametro pilorico del paciente y despues de ingerirlo en estado alimentado, la longitud del comp
MX2009002031A (es) 2006-08-25 2009-03-06 Boehringer Ingelheim Int Sistema de liberacion controlada y metodo para fabricarlo.
EP1925307A1 (en) * 2006-11-03 2008-05-28 Emotional Brain B.V. Use of 3-alpha-androstanediol in the treatment of sexual dysfunction
EP2896624B1 (en) 2007-03-28 2016-07-13 Atir Holding S.A. Heterotricyclic compounds as serotonergic and/or dopaminergic agents and uses thereof
CL2008002693A1 (es) 2007-09-12 2009-10-16 Boehringer Ingelheim Int Uso de flibanserina para el tratamiento de sintomas vasomotores seleccionados de sofocos, sudores nocturnos, cambios de estado de animo e irritabilidad
EP2695932A1 (en) 2012-08-08 2014-02-12 Ab Nanol Technologies Oy Grease composition
SG11202101235QA (en) * 2018-08-07 2021-03-30 Ilylt Llc Compositions and methods for treating sexual dysfunction and enhancing sexual response and pleasure

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030055070A1 (en) * 1999-07-01 2003-03-20 Wilma Harrison Phosphodiesterase type 5 (PDE5) inhibitors for the treatment of selective serotonin reuptake inhibitor (SSR) induced sexual dysfunction
US20020052370A1 (en) * 2000-07-06 2002-05-02 Barber Christopher Gordon Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
GB0105893D0 (en) * 2001-03-09 2001-04-25 Pfizer Ltd Pharmaceutically active compounds
GB0106446D0 (en) * 2001-03-15 2001-05-02 Vernalis Res Ltd Chemical compounds
UA78974C2 (en) * 2001-10-20 2007-05-10 Boehringer Ingelheim Pharma Use of flibanserin for treating disorders of sexual desire
GB0225908D0 (en) * 2002-11-06 2002-12-11 Pfizer Ltd Treatment of female sexual dysfunction

Also Published As

Publication number Publication date
MXPA06000623A (es) 2006-04-11
WO2005007166A1 (en) 2005-01-27
CA2532252A1 (en) 2005-01-27
TW200505410A (en) 2005-02-16
JP2007516949A (ja) 2007-06-28
EP1653966A1 (en) 2006-05-10

Similar Documents

Publication Publication Date Title
BRPI0411985A (pt) tratamento da disfunção sexual
MX2010000098A (es) Derivados de guanina policiclicos y sus metodos de uso.
PH12014501440A1 (en) Use of 3-alpha-androstanediol, optionally in combination with a 5-ht1a agonist, in the treatment of sexual dysfunction
NO20072558L (no) Mitotiske kineseinhibitorer og fremgangsmater for anvendelse derav
MX2010002732A (es) Inhibidores de f1f0-atpasa y metodos relacionados.
EA201290964A1 (ru) Пептидные конъюгаты агонистов рецептора glp-1 и их применение
CL2007001318A1 (es) Uso de flibanserina,opcionalmente como base libre,sal hidrato o solvato de ella,para preparar un medicamento util en el tratamiento de trastornos de deseo sexual en mujeres.
BR122019021238B8 (pt) uso de um inibidor do receptor da interleucina-6 (il-6) no tratamento da doença do enxerto versus hospedeiro (gvhd)
CY1112067T1 (el) Χρηση φλιμπανσερινης για την θεραπεια διαταραχων προ-εμμηνοπαυσιακης σεξουαλικης επιθυμιας
EA201491697A1 (ru) Составы агонистов гуанилатциклазы с и способы применения
EA201170288A1 (ru) Оксабициклогептаны и оксабициклогептены, их получение и применение
EA200870425A1 (ru) Применение агонистов рецептора grp119 для повышения костной массы и для лечения остеопороза и связанной с ними комбинированной терапии
MX2010004219A (es) Agentes de enlace de cd19 y usos de los mismos.
GT201200189A (es) Antagonistas de pcsk9
EA201170252A1 (ru) Амидофеноксиндазолы в качестве ингибиторов c-мет
EA200970737A1 (ru) Оксабициклогептаны и оксабициклогептены, их получение и применение
MX2009000169A (es) Derivados de purinona como agonistas de hm74a.
EA200601074A1 (ru) Применение производных пептидов для лечения болей, связанных с заболеванием центральной нервной системы (центральной невропатической боли)
GT200600442A (es) Inhibidores de pde y combinaciones de los mismos para el tratamiento de trastornos urologicos
AR113492A2 (es) Furina recombinante libre de proteínas sustancialmente animal y métodos para producirla
CL2008001074A1 (es) Uso de compuestos de triazol, antagonistas de smo para tratar cancer.
EA200701592A1 (ru) Композиты и способы их получения и использования
GB2464240A (en) Unitary Hair Clip and Method of Use
MA32932B1 (fr) Inhibiteurs de hsp90 utiles dans un traitement therapeutique
EA201100605A1 (ru) Комбинированная терапия, включающая ингибитор dhodh и метотрексат, для лечения аутоиммунного заболевания

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE AS 6A E 7A ANUIDADES.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.